Experimental Treatment Studies with Cernilton® in Human Benign Prostatic Hyperplasia
نویسندگان
چکیده
Despite the high incidence of benign prostatic hyperplasia (BPH), so far a conservative treatment modality has not been established internationally (4,5). The reasons for this are the multifactorial etiology of the symptoms in patients with BPH (5) and the lack of suitable animal models to elucidate the pathogenesis of BPH (5,9). This makes the search for conservative therapies aimed at the underlying causes of the disease process difficult. Futhermore, all clinical trials in patients with BPH are complicated by a very strong placebo effect. Currently, patients with BPH up to stage III according to Vahlensieck are treated conservatively with phytotherapy in Germany (11,12).
منابع مشابه
Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study.
Whilst prostatectomy remains the "gold standard" for the treatment of outflow tract obstruction due to benign prostatic hyperplasia, medical treatment--if only for symptomatic relief--appears to be an attractive alternative. Most of the pharmacological agents in use block the hormonal or the sympathetic neurological pathways that influence prostate growth and function. All of these drugs are kn...
متن کاملTherapeutic efficacy of Cernilton in benign prostatic hyperplasia patients with histological prostatitis after transurethral resection of the prostate.
OBJECTIVE This study was to prospectively evaluate the therapeutic efficacy of Cernilton in benign prostatic hyperplasia (BPH) patients with histological prostatitis after transurethral resection of the prostate (TURP). MATERIALS AND METHODS One hundred patients with histological prostatitis were recruited from January 2007 to January 2013. All patients were divided into groups A (mild), B (m...
متن کاملConservative Treatment of Benign Prostatic Hyperplasia (BPH) with Cernilton N – Results of a placebo-controlled double-blind study
The efficacy and tolerability of the pollen-extract preparation, Cernilton N*1, were investigated in a double-blind, placebo-controlled study carried out over a treatment period of 12 weeks in 6 urological practices, in a total of 103 patients suffering from benign prostatic hyperplasia (BPH) in Stages II and III. The investigational parameters were the disturbances of micturition classied acco...
متن کاملNon – Detection of HPV DNA in Prostatic Cancer and Benign Prostatic Hyperplasia: a case- control study in Kerman
Background: Different studies assessed the role of inflammation in malignancy of different organs. Prostatitis has been suggested as a cause of cancer and BPH. Till now, more than 100 types of human Papilloma virus (HPV) are recognized including low and high-risk groups for carcinogenesis. Among them HPV-16 and HPV-18 have shown further association with cancer. Regarding the pr...
متن کاملEvaluation of c-Myc mRNA Expression Level in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma Tissues and Its Correlation with Clinicopathological Characteristics
Background and Aims: Prostate cancer (PCa) is one of the most common cancers among men in Iran. Since changes in the regulation of proto-oncogenes expression are the main causes of most human cancers, including PCa, evaluating the expression of marker genes can be helpful for early diagnosis of cancer and better understanding of its etiology. The present study compared c-Myc expression level in...
متن کامل